Oaktree Specialty Lending Corporation Share Price

Equities

OCSL

US67401P4054

Closed End Funds

Market Closed - Nasdaq 21:00:00 26/04/2024 BST 5-day change 1st Jan Change
19.83 USD +0.81% Intraday chart for Oaktree Specialty Lending Corporation +0.46% -2.89%
Sales 2024 * 398M 31.83B Sales 2025 * 397M 31.8B Capitalization 1.57B 125B
Net income 2024 * 148M 11.85B Net income 2025 * 178M 14.25B EV / Sales 2024 * 7.91 x
Net Debt 2024 * 1.58B 127B Net Debt 2025 * 1.68B 135B EV / Sales 2025 * 8.17 x
P/E ratio 2024 *
10.6 x
P/E ratio 2025 *
8.79 x
Employees -
Yield 2024 *
11.2%
Yield 2025 *
11.1%
Free-Float 96.19%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Oaktree Specialty Lending Corporation

1 day+0.81%
1 week+0.46%
Current month+0.86%
1 month+2.16%
3 months-7.94%
6 months+4.92%
Current year-2.89%
More quotes
1 week
19.55
Extreme 19.55
19.88
1 month
19.18
Extreme 19.18
19.88
Current year
18.95
Extreme 18.95
21.64
1 year
17.99
Extreme 17.99
21.64
3 years
17.59
Extreme 17.5938
23.43
5 years
6.99
Extreme 6.99
23.43
10 years
6.99
Extreme 6.99
30.60
More quotes
Managers TitleAgeSince
Chief Executive Officer 48 29/09/19
President 59 16/10/17
Director of Finance/CFO 43 29/11/21
Members of the board TitleAgeSince
Director/Board Member 71 30/09/17
Chairman 68 16/10/17
Director/Board Member 66 06/09/17
More insiders
Date Price Change Volume
26/04/24 19.83 +0.81% 402,679
25/04/24 19.67 -0.10% 330,192
24/04/24 19.69 +0.25% 364,276
23/04/24 19.64 +0.20% 744,717
22/04/24 19.6 -0.71% 497,872

Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm

More quotes
Oaktree Specialty Lending Corporation is a specialty finance company. The Company provide customized, one-stop credit solutions to companies with limited access to public or syndicated capital markets. The Company's investment objective is to generate current income and capital appreciation by providing companies with flexible and financing solutions, including first and second lien loans, unsecured and mezzanine loans, bonds, preferred equity and certain equity co-investments. The Company may also seek to generate capital appreciation and income through secondary investments at discounts to par in either private or syndicated transactions. Its portfolio of investments includes application software, multi-sector holdings, data processing and outsourced services, pharmaceuticals, biotechnology, health care services, specialized finance, personal products, and more. The Company is externally managed by Oaktree Fund Advisors, LLC (Oaktree).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
19.83 USD
Average target price
20.44 USD
Spread / Average Target
+3.06%
Consensus